Allergenix

Biosensis specializes in antibodies and reagents for Neuroscience. Our
neuroscience portfolio includes products for research in neurodegenerative
diseases, neurodevelopment,and neuro-metabolism. Areas of focus include
Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and
metabolic and stress disorders including metabolic syndrome research,
obesity, and neuroimmunology and inflammation with particular emphasis on
neurotrophins and neurotrophin receptors for which Biosensis has been the
worldwide leader and OEM supplier for more than 30 years.
Biosensis also offers more than 200 high-quality ELISA kits for a wide range
of protein targets. Our assays are validated for a variety of sample matrices and where possible, tested by independent research laboratories. Our ELISA kits are complete, ready-to-use and without the need for additional reagents, buffers or plates. Plus our strip format allows you to only use what you need! Our detailed protocols include extensive information about sample preparation, assay execution, data analysis and validation. Full technical support is also provided by our highly skilled technical team at biospeak@biosensis.com.

Our new range of RapidTM ELISA assays can be performed in less than 4 hours
without compromising on accuracy, specificity and sensitivity. These assays
target potential biomarkers, such as oligomeric Aβ peptides (Alzheimer's
Disease, AD), mature BDNF (psychiatric disorders), proNGF (cancer) and
p75NTR/NGFR (Amytrophic Lateral Sclerosis, ALS).
Why purchase from Biosensis?
Biosensis is a company formed by a team of life scientists and business
people dedicated to the support of researchers in academia and industry
worldwide. The team has a combined total of over 50 years experience in the
commercialization of life science reagents for the life science research and diagnostic markets. We are therefore able to offer a level of customer support and expertise unmatched in the neuroscience reagent industry.

Healthy Animals. Let's Make It Happen, Together.

At Argenta we've been dedicated to animal health from day one. Since 2006, we've been a trusted partner to clients who need our expertise, partnership and no-challenge-too-tough attitude to bringing innovative new animal health products to market.

Because we are the only global CRO and CMO specializing in animal health, we are uniquely able to offer clients of all sizes a comprehensive product development solution from Molecule to Market, at any scale.

The day-to-day ethos that drives our company forward is a mission focused on global partnerships, a Molecule to Market approach, and of course, innovation.

At the core of our business and our organisation is collaboration — among our global team and with our customers. Working together, we continually challenge ourselves and each other to continue to innovate to develop the best animal health technologies and products possible.

From animal scientists to veterinarians to engineers and other industry experts, our 450+ strong global team is a passionate and diverse group united in their commitment to healthy animals.

We operate from Research & Development locations in New Zealand and the US and (EMA and FDA) GMP approved Manufacturing sites in New Zealand, the United Kingdom (Scotland) and the United States (Fort Dodge, Iowa).

Our company was founded in New Zealand by Doug Cleverly, a scientist who naturally felt more at home in the lab solving problems than in the boardroom. Doug imbued the company with the spirit of Kiwi ingenuity and a global perspective. He saw a need in the market for an animal health company that could provide the highest quality services to customers of all sizes, all over the world. To this day, we are still dedicated to animal health and our founder's legacy of problem solving and inventiveness lives on within the organisation.

Let’s get in touch!

Avance Clinical is the largest full-service Australian CRO specializing in delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs.

Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years.

The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.

As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of Avance Clinical’s trusted technology partners.

Visit http://www.avancecro.com for more information.


Recent Awards:
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020

Datapharm is Australia’s original independent full-service Contract Research Organisation (CRO), est. 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management (including eCRFs), medical writing, pharmacovigilance and auditing.
Datapharm has earned an enviable reputation for quality, following involvement in hundreds of clinical trials in over 35 therapeutic areas, Phases I (including first-in-human) to IV, for Big Pharma, Biotech, Medical Device companies and Non-profit organisations.
Datapharm works to ICH GCP and international regulatory authority standards with an overlay of excellent project management to achieve project milestones.
Datapharm offers services internationally through the global CRO consortium DAI-SYS.

Novotech is internationally recognized as a leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety solutions, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.